Analyst firms · Jefferies · BIOA
Jefferies BIOA price target and rating history
BioAge Labs Inc. (BIOA) · Health Care
Jefferies rates BioAge Labs Inc. (BIOA) Buy with a $62 price target, as of its latest action on Feb 18, 2026. It has published 3 rating actions on BIOA since October 2024, including 1 upgrade and 1 downgrade. Across 8 firms with a BIOA price target in the last 12 months, the median target is $45. Jefferies's $62 is 38% above that.
- Current rating
- Buy
- Price target
- $62
- Median target, all firms
- $45
- Actions on BIOA
- 3
Jefferies price target on BIOA
Every Jefferies rating on BIOA
- Feb 18, 2026
- Dec 9, 2024
- Oct 21, 2024
How other firms rate BIOA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Neutral | $8 | Oct 12, 2026 |
| Roth Capital | Buy | $36 | May 27, 2026 |
| BTIG | Buy | $40 | May 13, 2026 |
| Needham | Buy | $50 | Mar 27, 2026 |
| Oppenheimer | Outperform | $60 | Feb 25, 2026 |
| Jefferies | Buy | $62 | Feb 18, 2026 |
| Piper Sandler | Overweight | $73 | Jan 27, 2026 |
| Morgan Stanley | Equal-Weight | $12 | Dec 5, 2025 |
Questions about Jefferies and BIOA
- What is Jefferies's price target for BIOA?
- Jefferies's latest stated price target for BioAge Labs Inc. (BIOA) is $62, from its action on Feb 18, 2026.
- What is Jefferies's rating on BIOA?
- Jefferies rates BIOA Buy, a bullish rating, as of Feb 18, 2026.
- When did Jefferies last change its view on BIOA?
- On Feb 18, 2026, Jefferies upgrades to Buy from Hold, price target $62.
- How does Jefferies's BIOA target compare with other analysts?
- Across 8 firms with a BIOA price target in the last 12 months, the median target is $45. Jefferies's $62 is 38% above that.
More BIOA rating histories
All Jefferies ratingsBIOA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.